March 13–16, 2026 | London, United Kingdom | Booth #M12

As a global developer, manufacturer, and distributor of radiopharmaceuticals, we are committed to shaping the future of theranostic innovation in prostate cancer.

Join us in London to discover how Curium is expanding access to PSMA PET and transforming clinical practice with AI-powered precision tools.

Experiment Pylclari AI^{® ,}

Curium’s intelligent assistant designed to enhance the accuracy, consistency, and efficiency of PSMA PET/CT interpretation.

Built to support nuclear medicine physicians and multidisciplinary teams, Pylclari AI® delivers reliable quantitative insights and standardized reporting — helping drive confident clinical decisions.

Book Your Demo Today!

Why Pylclari AI^®?

✔ Quantitative – Precise whole-body PSMA PET/CT assessment.
✔ Reproducible – Consistent reports for initial and follow-up scans.
✔ Standardized – Clear, comprehensive reporting for better decisions.

See It in Action

🔹 Book a 15-minute live demo at Booth #M12
🔹 Meet our medical and commercial experts
🔹 Explore Curium’s latest developments in theranostics for urological diseases
🔹 Learn how we are widening access to PSMA PET

Experience firsthand how AI-powered quantification can support your clinical workflow.

Secure Your Demo Slot